AllianceBernstein’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-229,846
Closed -$6.58M 3163
2018
Q4
$6.58M Buy
229,846
+7,218
+3% +$205K ﹤0.01% 1178
2018
Q3
$6.21M Buy
222,628
+74,490
+50% +$2.09M ﹤0.01% 1172
2018
Q2
$4.13M Sell
148,138
-4,565
-3% -$122K ﹤0.01% 1374
2018
Q1
$3.8M Sell
152,703
-36,500
-19% -$888K ﹤0.01% 1369
2017
Q4
$4.58M Sell
189,203
-124,807
-40% -$3.29M ﹤0.01% 1265
2017
Q3
$8.67M Buy
314,010
+220,000
+234% +$5.87M 0.01% 993
2017
Q2
$2.36M Hold
94,010
﹤0.01% 1721
2017
Q1
$2.52M Sell
94,010
-15,300
-14% -$423K ﹤0.01% 1642
2016
Q4
$2.87M Hold
109,310
﹤0.01% 1576
2016
Q3
$2.73M Hold
109,310
﹤0.01% 1545
2016
Q2
$2.37M Buy
109,310
+16,100
+17% +$287K ﹤0.01% 1557
2016
Q1
$1.4M Hold
93,210
﹤0.01% 1884
2015
Q4
$2.04M Sell
93,210
-5,700
-6% -$106K ﹤0.01% 1594
2015
Q3
$1.56M Sell
98,910
-6,240
-6% -$100K ﹤0.01% 1859
2015
Q2
$1.5M Buy
105,150
+1,300
+1% +$22K ﹤0.01% 2021
2015
Q1
$1.8M Hold
103,850
﹤0.01% 1801
2014
Q4
$1.86M Sell
103,850
-17,450
-14% -$281K ﹤0.01% 1802
2014
Q3
$1.59M Sell
121,300
-792
-0.6% -$10.7K ﹤0.01% 1886
2014
Q2
$1.75M Buy
122,092
+1,800
+1% +$23.5K ﹤0.01% 1872
2014
Q1
$1.53M Hold
120,292
﹤0.01% 1897
2013
Q4
$1.2M Hold
120,292
﹤0.01% 2055
2013
Q3
$1.58M Buy
120,292
+3,143
+3% +$41.2K ﹤0.01% 1845
2013
Q2
$1.67M Buy
+117,149
New +$1.47M ﹤0.01% 1745

Other funds holding NXTM

AllianceBernstein's NXTM Position: Q1 2019 in Review

AllianceBernstein sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 229,846 shares — an estimated $6.58M sold.

AllianceBernstein first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $8.67M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • AllianceBernstein reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • AllianceBernstein sold 229,846 NxStage Medical Inc. shares in Q1 2019, an estimated $6.58M.
  • AllianceBernstein first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • AllianceBernstein's NxStage Medical Inc. position peaked at $8.67M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on AllianceBernstein's 13F filing for Q1 2019, filed 14 May 2019.